Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Gil

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Cancer Research|December 20, 2018
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i>-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkMarta Román, Inés López, Elisabeth Guruceaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2023
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in <i>NRAS</i>-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label StudyFilippo de Braud, Christophe Dooms, Rebecca S Heist, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.
Thrombosis Research|November 17, 2023
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancerInmaculada Aparicio, Patricia Iranzo, Roxana Reyes, et al.
JCO Global Oncology|August 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent ConsiderationsChristian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, et al.
Cancer Medicine|May 17, 2018
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancerJuan Pablo Fusco, Guillermo Pita, María José Pajares, et al.
Cell Communication and Signaling : CCS|May 15, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2Jesús M Pérez-Gómez, Antonio Prats-Escribano, Ignacio Gil-Duque, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Cancer Letters|December 31, 2021
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasisSergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Cancer Research|December 20, 2018
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i>-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkMarta Román, Inés López, Elisabeth Guruceaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2023
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in <i>NRAS</i>-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label StudyFilippo de Braud, Christophe Dooms, Rebecca S Heist, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.
Thrombosis Research|November 17, 2023
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancerInmaculada Aparicio, Patricia Iranzo, Roxana Reyes, et al.
JCO Global Oncology|August 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent ConsiderationsChristian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, et al.
Cancer Medicine|May 17, 2018
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancerJuan Pablo Fusco, Guillermo Pita, María José Pajares, et al.
Cell Communication and Signaling : CCS|May 15, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2Jesús M Pérez-Gómez, Antonio Prats-Escribano, Ignacio Gil-Duque, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Cancer Letters|December 31, 2021
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasisSergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, et al.
Pageof 15